BofA/Merrill Lynch Downgrades Novartis (NVS) to Neutral
Tweet
Share
E-mailGet Alerts NVS Hot Sheet
Price: $150.88 -0.55%
Rating Summary:
7 Buy, 14 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
7 Buy, 14 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
BofA/Merrill Lynch downgraded Novartis (NYSE: NVS) from Buy to Neutral.
For more ratings news on Novartis click here and for the rating history of Novartis click here.
Shares of Novartis closed at $55.42 yesterday.
For more ratings news on Novartis click here and for the rating history of Novartis click here.
Shares of Novartis closed at $55.42 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Resumes American Eagle Outfitters (AEO) at Underperform
- BofA says US yen intervention may need stronger follow-up
- Lake Street Downgrades SoundThinking (SSTI) to Hold
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
